We are live on
!
Find out more
EEG
E.E. Geduld Portfolio holdings
AUM
$178M
1-Year Est. Return
29.34%
This Fund
S&P 500
This Quarter
Est. Return
+5.61%
1 Year Est. Return
+29.34%
3 Year Est. Return
+59.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$185M
AUM Growth
-$21.9M
(-11%)
Cap. Flow
+$579K
Cap. Flow
% of AUM
0.31%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
415
New
80
Increased
38
Reduced
43
Closed
102
Avg Time Held Equity + Options
1.8
quarters
Top 10 Avg Time Held Equity + Options
0.8
quarters
Top 20 Avg Time Held Equity + Options
1.2
quarters
Avg Time Held Equity only
1.9
quarters
Top 10 Avg Time Held Equity only
1.3
quarters
Top 20 Avg Time Held Equity only
1.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$4.64M |
| 2 |
Lindsay Corp
LNN
|
+$2.12M |
| 3 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$1.77M |
| 4 |
Boston Scientific
BSX
|
+$1.51M |
| 5 |
Verizon
VZ
|
+$1.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.34M |
| 2 |
3D Systems Corp
DDD
|
+$1.86M |
| 3 |
Lennar Class A
LEN
|
+$989K |
| 4 |
BlackBerry
BB
|
+$938K |
| 5 |
Vince Holding Corp
VNCE
|
+$928K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 31.91% |
| 2 | Miscellaneous | 27.85% |
| 3 | Healthcare | 13.47% |
| 4 | Technology | 9.49% |
| 5 | Consumer Discretionary | 3.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Bank of America
BAC
$381B
| $43.4M | 23.44% |
2,524,548
| – | – |
2013 Q2
3 quarters
|
|
|
2
Johnson & Johnson
JNJ
$634B
| $4.91M | 2.65% |
+50,000
| New | +$4.64M |
2014 Q1
0 quarters
|
|
|
3
Boston Scientific
BSX
$62.6B
| $2.71M | 1.46% |
200,110
+115,110
| +135% | +$1.51M |
2013 Q2
3 quarters
|
|
|
4
CALL
Bank of America
BAC
$381B
| $2.58M | 1.39% |
150,000
+40,000
| +36% | +$673K |
2013 Q2
3 quarters
|
|
5
DELISTED
Hess
HES
| $2.5M | 1.35% |
30,200
+5,000
| +20% | +$397K |
2013 Q2
3 quarters
|
|
6
CALL
Microsoft
MSFT
$4T
| $2.46M | 1.33% |
60,000
-5,000
| -8% | -$188K |
2013 Q2
3 quarters
|
|
7
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$821B
| $2.34M | 1.26% |
+12,500
| New | +$2.29M |
2014 Q1
0 quarters
|
|
|
ARIA
8
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $2.24M | 1.21% |
277,600
-557,500
| -67% | -$4.34M |
2013 Q4
1 quarter
|
|
|
HEOP
9
DELISTED
Heritage Oaks Bancorp
HEOP
| $2.22M | 1.2% |
275,000
| – | – |
2013 Q2
3 quarters
|
|
|
10
Lindsay Corp
LNN
$1.16B
| $2.21M | 1.19% |
+25,009
| New | +$2.12M |
2014 Q1
0 quarters
|
|
11
DELISTED
Denny's
DENN
| $1.9M | 1.02% |
295,000
-15,000
| -5% | -$101K |
2013 Q2
3 quarters
|
|
12
CALL
Medtronic
MDT
$117B
| $1.85M | 1% |
+30,000
| New | +$1.75M |
2014 Q1
0 quarters
|
|
13
Columbia Banking Systems
COLB
$8.08B
| $1.75M | 0.94% |
61,290
| – | – |
2013 Q2
3 quarters
|
|
14
DELISTED
General Motors Company
GM.WS.B
| $1.68M | 0.9% |
96,287
| – | – |
2013 Q2
3 quarters
|
|
|
15
Verizon
VZ
$177B
| $1.67M | 0.9% |
35,100
+30,100
| +602% | +$1.42M |
2013 Q2
3 quarters
|
|
16
Acadia Pharmaceuticals
ACAD
$3.36B
| $1.67M | 0.9% |
68,500
-6,500
| -9% | -$164K |
2013 Q2
3 quarters
|
|
|
FNM
17
DELISTED
FANNIE MAE
FNM
| $1.56M | 0.84% |
400,000
+125,000
| +45% | +$488K |
2013 Q3
2 quarters
|
|
|
MNDT
18
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $1.54M | 0.83% |
+25,000
| New | +$1.77M |
2014 Q1
0 quarters
|
|
|
NPSP
19
DELISTED
NPS PHARMACEUTICALS INC
NPSP
| $1.5M | 0.81% |
50,000
-10,000
| -17% | -$345K |
2013 Q2
3 quarters
|
|
|
FRNK
20
DELISTED
FRANKLIN FINL CORP VA COM STK (VA)
FRNK
| $1.37M | 0.74% |
70,000
-5,000
| -7% | -$97.2K |
2013 Q2
3 quarters
|
|
|
LTS
21
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $1.36M | 0.73% |
450,000
| – | – |
2013 Q2
3 quarters
|
|
22
CALL
Loews
L
$22B
| $1.32M | 0.71% |
+30,000
| New | +$1.34M |
2014 Q1
0 quarters
|
|
|
23
Loews
L
$22B
| $1.32M | 0.71% |
+30,000
| New | +$1.34M |
2014 Q1
0 quarters
|
|
24
Intel
INTC
$535B
| $1.29M | 0.7% |
+50,000
| New | +$1.25M |
2014 Q1
0 quarters
|
|
25
CALL
Vanguard FTSE Europe ETF
VGK
$29.3B
| $1.18M | 0.64% |
20,000
-5,000
| -20% | -$292K |
2013 Q4
1 quarter
|
|
Similar funds
BC
PFM
SRP
CF
SA
WSA
SIG
VWM
E.E. Geduld's Q1 2014 Portfolio in Review
As of Q1 2014, E.E. Geduld held 415 positions worth $185M, down 11% from $207M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
E.E. Geduld's Q1 2014 filing shows 80 new, 38 increased, 43 reduced and 102 closed positions. Its largest new stake was Johnson & Johnson: 50,000 shares worth $4.91M. The largest sale was Ariad Pharmaceuticals Inc, an estimated $4.34M.
By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 26% a quarter earlier, followed by Miscellaneous and Healthcare.
- E.E. Geduld's largest Q1 2014 buy was Johnson & Johnson: 50,000 shares worth $4.91M.
- E.E. Geduld added most to Boston Scientific in Q1 2014, an estimated $1.51M increase.
- E.E. Geduld's biggest Q1 2014 reduction was Ariad Pharmaceuticals Inc, cutting an estimated $4.34M.
- E.E. Geduld fully exited 3D Systems Corp in Q1 2014, selling an estimated $1.86M.
- E.E. Geduld's ten largest holdings make up 38% of its $185M portfolio in Q1 2014.
- E.E. Geduld opened 80 new positions and closed 102 in Q1 2014.
- E.E. Geduld's portfolio value fell 11% quarter-over-quarter to $185M.
Based on E.E. Geduld's 13F filing for Q1 2014, filed 7 May 2014.